SUPT4H1P2

Across TCGA pan-cancer cohorts, SUPT4H1P2 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SUPT4H1P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SUPT4H1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SUPT4H1P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and GBM show a favorable association.

KIRC, ACC, and BLCA are the cancer types where SUPT4H1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.753	0.824	.005	26	view →
ACC	DFS	Tertile	III,IV	0.072	0.484	.007	24	view →
BLCA	DFS	Tertile	IV	0.106	0.478	.001	18	view →
SKCM	OS	Tertile	III,IV	0.895	0.787	.032	15	view →
STAD	DFS	Median	II,III,IV	0.228	0.519	.007	15	view →
GBM	OS	Quartile	All	0.468	0.289	.016	6	view →
PAAD	OS	Tertile	All	0.237	0.419	.044	6	view →
UVM	DFS	Tertile	All	0.839	0.529	.046	3	view →
LUSC	OS	Quartile	III,IV	0.418	0.809	.047	3	view →
ESCA	OS	Quartile	III,IV	0.416	0.725	.039	3	view →
COAD	DFS	Median	All	0.751	0.654	.032	3	view →
TGCT	DFS	Median	All	0.906	0.757	.047	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SUPT4H1P2–KIRC (OS)

Open the KIRC breakdown →